Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes.
Four mycobacterial wall glycolipids were tested for their effects on phospholipidic liposome organization and passive permeability and on oxidative phosphorylation of isolated mitochondria. From fluorescence polarization of diphenylhexatriene performed on liposomes it was concluded that the two trehalose derivatives (dimycoloyltrehalose and polyphthienoyltrehalose) rigidified the fluid state of liposomes, the triglycosyl phenolphthiocerol slightly fluidized the gel state, while the peptidoglycolipid ("apolar" mycoside C) just shifted the phase transition temperature upward. Dimycoloyltrehalose was without effect on liposome passive permeability, as estimated from dicarboxyfluorescein leak rates, and polyphthienoyltrehalose and triglycosyl phenolphthiocerol slightly decreased leaks, while mycoside C dramatically increased leaks. Activity of these lipids on mitochondrial oxidative phosphorylation was examined. The two trehalose derivatives have been tested previously: both had the same type of inhibitory activity, dimycoloyltrehalose being the most active. Triglycosyl phenolphthiocerol was inactive. Mycoside C was very active, with effects resembling those of classical uncouplers: this suggested that its activity on mitochondria was related to its effect on permeability. All these membrane alterations were called nonspecific because it is likely that they result from nonspecific lipid-lipid interactions, and not from recognition between specific molecular structures. Such nonspecific interactions could be at the origin of some of the effects of mycobacteria glycolipids on cells of the immune system observed in the last few years.
Sut
A
A
Centre de Biochimie et Génétique Cellulaires du CNRS, Toulouse, France.
Sirugue
S
S
Sixou
S
S
Lakhdar-Ghazal
F
F
Tocanne
J F
JF
Lanéelle
G
G
D000818:Animals; D003311:Cord Factors / Q000737:chemistry / Q000494:pharmacology; D006017:Glycolipids / Q000737:chemistry* / Q000494:pharmacology / Q000502:physiology; D006020:Glycopeptides / Q000737:chemistry / Q000494:pharmacology / Q000502:physiology; D008051:Lipid Bilayers; D008081:Liposomes; D008560:Membrane Fluidity / Q000187:drug effects; D008563:Membrane Lipids / Q000737:chemistry* / Q000494:pharmacology / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects; D015394:Molecular Structure; D009161:Mycobacterium / Q000472:pathogenicity / Q000648:ultrastructure*; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity / Q000648:ultrastructure*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010743:Phospholipids; D051381:Rats
D003311:Cord Factors; D006017:Glycolipids; D006020:Glycopeptides; D008051:Lipid Bilayers; D008081:Liposomes; D008563:Membrane Lipids; D010743:Phospholipids; C010762:peptidoglycolipids; C066561:polyphthienoyltrehalose; C066562:triglycosyl phenolphthiocerol